SCHEMBL6027254

SCHEMBL6027254

O=C(Nc1ccc(-c2ncc(-c3cccc(NC45CC6CC(CC(C6)C4)C5)c3)[nH]2)cc1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 2/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.43
CNR2 P34972 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TSHR P16473 1/20 0.41
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 2/20 0.40
USP2 O75604 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
ALOX5 P09917 2/20 0.39
EPHX2 P34913 1/20 0.39
STS P08842 1/20 0.39
ENPP3 O14638 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027057 0.94 ALDH1A1 (0.48) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6888848 0.93 ALDH1A1 (0.52) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6887915 0.90 CNR2 (0.46) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6888182 0.88 ALDH1A1 (0.52) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL13663138 0.79 SMN1; SMN2 (0.51) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6887918 0.78 SCN2A (0.45)
SCHEMBL6887211 0.77 TP53 (0.52) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL5621233 0.76 ALDH1A1 (0.53) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6027187 0.75 PTPN1 (0.48) ALDH1A1KDM4ETP53HPGDSMN1; SMN2
SCHEMBL6026686 0.75 PTPN1 (0.48) ALDH1A1KDM4ETP53HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613310-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS Avanir Pharmaceuticals (US) 2006-01-11 EP disclosed
WO-2004091610-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS AVANIR PHARMACEUTICALS (US) 2004-10-28 WO disclosed